Manufacturing and Production

Showing 15 posts of 5882 posts found.

UK takes action to prevent API shortages

June 20, 2013 Manufacturing and Production API, MHRA, shortages

The UK has unilaterally adopted a policy of allowing imports of active pharmaceutical ingredients (API) on the strength of pharmaceutical …
screen_shot_2013-06-20_at_09

InHealthcare appoints NHS director

June 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing InHealthcare

Digital healthcare firm InHealthcare has appointed NHS director Simon Jones as its new commercial director.Jones has held positions in Acute Hospitals, Mental Health and …

Nine fined in EU pay-for-delay deals

June 20, 2013 Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy

Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …
united_drug

United Drug hires Abbott VP

June 19, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Abbott, United Drug

Healthcare services firm United Drug has appointed Brendan McAtamney as chief operating officer with effect from September. McAtamney will be …
ISPE survey image

Quality issues ‘leading cause of drug shortages’

June 18, 2013 Manufacturing and Production ISPE, shortages

Shortages of key medicines have been increasing in recent years, and a new survey from the International Society for Pharmaceutical …
Eisai image

Eisai’s £8 million UK expansion

June 17, 2013 Manufacturing and Production Eisai

Eisai has decided to invest further into its Hertfordshire production plant in the UK towards the creation of an additional …
neil_mculloch_icon

ICON appoints executive vice president

June 17, 2013 Manufacturing and Production, Research and Development, Sales and Marketing ICON

Clinical research organisation ICON has appointed Dr Neil McCullough as executive vice president of Quality and Compliance and Corporate Training.McCullough …
John LaMattina

John LaMattina: Pharma’s R&D deals with foundations may hit reputations

June 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina

On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), …
Catalent image

Catalent breaks ground on $35m controlled-release facility

June 17, 2013 Manufacturing and Production Catalent

Catalent Pharma Solutions has started construction of a new facility at its site in Winchester, Kentucky, that will boost its …
Teva image

No evidence of fault at Teva plant linked to drug switch death

June 14, 2013 Manufacturing and Production Teva, death

France’s medicines regulator has concluded that a plant operated in the country by generic drugmaker Teva was not at fault …
ingo-bank_parexel

PAREXEL appoints senior VP and CFO

June 14, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parexel

Biopharma services provider PAREXEL has appointed Ingo Bank to be a senior VP and chief financial officer at the firm. …
Baxter image

Baxter warned by FDA over repeat failings at two plants

June 14, 2013 Manufacturing and Production FDA, baxter

Baxter has attracted the ire of the US Food and Drug Administration over quality failures at two sterile product manufacturing …
karpecki

Paul Karpecki joins Freedom Meditech Scientific Advisory Board

June 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Freedom meditech

Medical device company Freedom Meditech has appointed Dr Paul Karpecki to its Scientific Advisory Board. Karpecki currently works in corneal …

Almac creates 229 jobs in Northern Ireland expansion

June 13, 2013 Manufacturing and Production Almac, Ireland, laxative

Northern Ireland-based Almac is planning to invest almost £14 million in another expansion of its pharma development and manufacturing operation …
stelios_papadopoulos

Regulus names Stelios Papadopoulos as chairman

June 12, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, Exelixis, Regulas

Biopharma firm Regulas Therapeutics has named Stelios Papadopoulos chairman of its Board of directors.  Papadopoulos assumes the role from John …
The Gateway to Local Adoption Series

Latest content




Five Facts about COPD

October 11, 2026